Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Attention Deficit Disorder Patients”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Not applicableLooking for participantsNCT06456372
What this trial is testing

Digital Health Intervention for Children With ADHD

Who this might be right for
ADHD
University of California, Riverside 60
Post-approval studies (Phase 4)Study completedNCT00261872
What this trial is testing

Treatment of Patients With Alcoholism and Attention Deficit Disorder

Who this might be right for
AlcoholismAttention Deficit Disorder
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 100
Not applicableStudy completedNCT03721588
What this trial is testing

Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD

Who this might be right for
Depressive Disorder, MajorAdult Attention Deficit Hyperactivity DisorderSuicide
Bozyaka Training and Research Hospital 96
Large-scale testing (Phase 3)Study completedNCT00922636
What this trial is testing

Pediatric Patients With Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 340
Post-approval studies (Phase 4)Study completedNCT00471354
What this trial is testing

Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 228
Testing effectiveness (Phase 2)Study completedNCT04027361
What this trial is testing

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
ADHD
Tris Pharma, Inc. 41
Not applicableUnknownNCT01651169
What this trial is testing

Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Tehran University of Medical Sciences 30
Not applicableStudy completedNCT01415440
What this trial is testing

Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
New York State Psychiatric Institute 117
Testing effectiveness (Phase 2)Study completedNCT01174355
What this trial is testing

ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit and Hyperactivity Disorder
NeuroDerm Ltd. 40
Not applicableUnknownNCT04845243
What this trial is testing

Effectiveness of a Short Computer-based Emotion Recognition Training in Different Patient Groups

Who this might be right for
Autism Spectrum DisorderConduct Disorder
Prof. Christina Stadler 80
Not applicableStudy completedNCT06005506
What this trial is testing

National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.

Who this might be right for
AdhdALSBronchial Asthma
Institute of Biomedical Technologies-National Research Council, Italy 64
Post-approval studies (Phase 4)Study completedNCT03661788
What this trial is testing

Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD

Who this might be right for
ADHD
RWTH Aachen University 38
Not applicableStudy completedNCT03878251
What this trial is testing

Outcomes Measures in Intellectual Disability

Who this might be right for
Attention Deficit in Intellectual Disability
Assistance Publique - Hôpitaux de Paris 40
Not applicableUnknownNCT06616337
What this trial is testing

Patients Suffering From Emotional Dysregulation

Who this might be right for
Emotional Dysregulation
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)Active Not RecruitingNCT02736656
What this trial is testing

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. 1,400
Testing effectiveness (Phase 2)Study completedNCT00664703
What this trial is testing

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Yaupon Therapeutics 13
Large-scale testing (Phase 3)Study completedNCT02139124
What this trial is testing

The Efficacy and Safety of PRC-063 in Adult ADHD Patients

Who this might be right for
ADHD
Rhodes Pharmaceuticals, L.P. 375
Not applicableStudy completedNCT03018574
What this trial is testing

Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)

Who this might be right for
Gene Product Sequence Variation
Xijing Hospital 100
Post-approval studies (Phase 4)Study completedNCT02477280
What this trial is testing

Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance

Who this might be right for
Attention Deficit Hyperactivity DisorderSubstance Use Disorder
Region Västmanland 39
Large-scale testing (Phase 3)Looking for participantsNCT05832489
What this trial is testing

EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders

Who this might be right for
Adult ADHDAdult-onset ADHD With Mood Disorder
University Hospital, Strasbourg, France 80
Next Page